The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity

Diabetologia

Volumn 45, Issue 4, 2002, Pages 584-587

  Hoffstedt, J ^a   Andersson, I L ^a   Persson, L ^a   Isaksson, B ^a   Arner, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adipose tissue; Body mass index; Fat; Genes; Humans; Obesity; Overweight; Plasmin activator inhibitor 1; Polymorphism; Single nucleotide polymorphism

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ALLELISM; ARTICLE; BODY MASS; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SCANDINAVIA; SINGLE NUCLEOTIDE POLYMORPHISM; BODY CONSTITUTION; BODY WEIGHT; DIABETES MELLITUS; GENETICS; SEXUAL DEVELOPMENT;

ADULT; BODY CONSTITUTION; BODY MASS INDEX; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; GENOTYPE; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; OBESITY IN DIABETES; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T; THINNESS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 0035988198     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0774-5     Document Type: Article

References (21)

1. The human obesity gene map: The 2000 update
2. Obesity - A genetic disease of adipose tissue?
3. Adipose tissue as an endocrine and paracrine organ
4. A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders
5. Hypofibrinolysis and increased PAI-1 are linked to atherosclerosis via insulin resistance and obesity
6. Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance
7. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity
8. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice
9. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells
10. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
11. Plasminogen-activator inhibitor type 1 and coronary artery disease
12. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: Relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome
13. Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease
14. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue
15. A novel G/A and the 4G/5G polymorphism with the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis
16. Five frequent polymorphisms of the PAI-1 gene: Lack of association between genotypes. PAI-1 activity, and triglyceride levels in a healthy population
17. The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden Carriers
18. Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1
19. Lipid messengers as targets for antiangiogenic therapy
20. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals
21. Expression of type I plasminogen activator inhibitor in chronic pulmonary thromboemboli